UK markets close in 8 hours 21 minutes

  • FTSE 100

    6,588.53
    0.00 (0.00%)
     

  • FTSE 250

    21,221.46
    0.00 (0.00%)
     

  • AIM

    1,192.17
    0.00 (0.00%)
     

  • GBP/EUR

    1.1564
    +0.0011 (+0.09%)
     

  • GBP/USD

    1.3880
    -0.0040 (-0.29%)
     

  • BTC-GBP

    34,907.74
    +1,505.04 (+4.51%)
     

  • CMC Crypto 200

    973.34
    -13.31 (-1.35%)
     

  • S&P 500

    3,901.82
    +90.67 (+2.38%)
     

  • DOW

    31,535.51
    +603.14 (+1.95%)
     

  • CRUDE OIL

    59.95
    -0.69 (-1.14%)
     

  • GOLD FUTURES

    1,716.10
    -6.90 (-0.40%)
     

  • NIKKEI 225

    29,408.17
    -255.33 (-0.86%)
     

  • HANG SENG

    29,082.49
    -370.08 (-1.26%)
     

  • DAX

    14,012.82
    +226.53 (+1.64%)
     

  • CAC 40

    5,792.79
    +89.57 (+1.57%)
     
Budget 2021:

£520m for 'MBA-style training' for small business owners

Tens of thousands of UK firms to be offered management training to increase innovation & boost growth

LINUS Digital Finance lays the foundation to scale up as a stock corporation and appoints Verena Mohaupt as Supervisory Board Chair and Christian Vollmann as Deputy Chair

·5-min read

DGAP-News: Linus Digital Finance AG / Key word(s): Personnel/Real Estate
17.02.2021 / 12:00
The issuer is solely responsible for the content of this announcement.

LINUS Digital Finance lays the foundation to scale up as a stock corporation and appoints Verena Mohaupt as Supervisory Board Chair and Christian Vollmann as Deputy Chair

- Supervisory Board Chair Verena Mohaupt, partner at a renowned private equity fund and Supervisory Board member at home24 and Pacifico Renewables Yield AG

- Other Supervisory Board members are business angel and tech entrepreneur Christian Vollmann (nebenan.de), attorney Jennifer Brenke (Leonhardt Rattunde) and venture capital expert Kristian Schmidt-Garve (MIG Verwaltungs AG)

- New structure to accelerate strategic growth and Europe-wide expansion


Berlin, 17 February 2021 -
LINUS Digital Finance becomes a stock corporation and appoints a Supervisory Board with four members. The adjustments to its structure and the addition of high calibre personnel allow the Berlin-based finance technology company to prepare itself for the rapid expansion of its business. The fintech company, founded in 2016, is the first German company to offer private individuals and small professional investors throughout the Eurozone direct, digital access to high-quality real estate investments through its proprietary finance platform. This allows LINUS to open up institutional investments in this asset class to a very large group of new investors formerly unable to access such lucrative opportunities.

Frederic Olbert, an investment banker previously with Goldman Sachs, joined LINUS to become its Chief Financial Officer. Together with founder and CEO David Neuhoff he will form the board of management of LINUS Digital Finance AG. Verena Mohaupt, an experienced member of numerous Supervisory Boards and a private equity investor, was appointed as Chair of the Supervisory Board. She will be joined by an interdisciplinary team comprising the business angel and tech entrepreneur Christian Vollmann (nebenan.de), the attorney Jennifer Brenke (Leonhardt Rattunde), and the venture capital investor Kristian Schmidt-Garve (MIG Verwaltungs AG).

"The new corporate form is the next logical step for LINUS to accelerate the already dynamic pace of our expansion. We look forward to working with our highly experienced Supervisory Board to broaden our product offering and to rapidly grow the number of clients that we provide digital access to institutional real estate investments throughout Europe to," stated David Neuhoff, CEO of LINUS Digital Finance.

Supervisory Board with extensive private equity, start-up and scaling experience

The members of the Supervisory Board have long and diverse track records in areas such as business and real estate law, private equity, M&A, venture capital, company building and business development.

Supervisory Board Chair Verena Mohaupt has extensive experience as a member of Supervisory Boards, including at home24 and Pacifico Renewables Yield AG, and as a partner in a renowned private equity fund. Verena Mohaupt has previously been employed at Allianz Capital Partners (ACP), McKinsey & Co. and at Goldman Sachs and was the co-founder and chair of ciao.com AG. She holds an MBA from INSEAD and a bachelor's degree in business administration from the University of Münster.

"I am very much looking forward to working with LINUS in writing the coming chapters in its wonderful success story. This fintech has demonstrated the enormous potential that investors can tap into at the intersection between digital platforms and real estate investments," said Verena Mohaupt, the Chair of the Supervisory Board of LINUS Digital Finance.

Christian Vollmann, a widely acknowledged expert in the field of start-ups, takes up the role of Deputy Chair of the Supervisory Board. The business administration graduate boasts an impressive track record having (co-)founded 75 companies since 2005, including the social network StudiVZ and the travel portal Trivago. In 2015, he founded the social neighbourhood network nebenan.de, which has 1.7 million users today. In 2017, Vollmann was honoured with the Business Angel of the Year award. He is also involved in PropTech1 Ventures as a venture partner and member of the investment committee. Proptech 1 Ventures is Germany's first venture capital fund primarily investing in the digitalisation of the real estate industry.

Strategic investments underline ambitious growth plans

LINUS Digital Finance is currently focusing on developing and promoting its digital platform www.linus-finance.com. The platform offers professional and semi-professional investors digital access to institutional real estate investments. The company plans to invest more than 10 million euros to scale the proprietary platform and to raise a total of more than one billion euros from co-investors in the medium term. To that end, the LINUS team is growing considerably with a large number of further hirings expected by the end of 2021.

About LINUS Digital Finance:
LINUS Digital Finance, located in Berlin and London, offers bespoke real estate project financing. LINUS always acts as the anchor investor in its mezzanine and whole-loan investments through its EUR 350m debt fund vehicle. Semi-professional and institutional investors are able to join LINUS' investments as co-investors through its proprietary digital finance platform. As an investment management company, LINUS is supervised by the German Federal Financial Supervisory Authority (Bundesanstalt für Finanzdienstleistungsaufsicht, BaFin). Since inception, LINUS has invested more than EUR 550 million of capital together with its co-investors into real estate projects financing a project volume in excess of EUR 1.5 billion.

Press contact:
Johannes Braun
PB3C GmbH
E-mail: braun@pb3c.com
Phone: +49 (0) 30 726276 1544


17.02.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

show this
show this

Latest stories

  • 21 Looks To Kick-Start Your Wardrobe’s Transition Into Spring

    Though it might not look like it outside depending on where you are, spring is almost here. And with it, comes an excuse to shed the layers of worn-to-death loungewear and coats we’ve been donning all winter, and perform a spring wardrobe overhaul. For you, a transitional spring outfit might involve a maximalist array of accessories, from prairie collars to lucite rings spotted on the runways and TikTok, respectively. If you prefer something more minimal, it’s time to pull out the baggy trousers and lightweight quilted jackets. Either way, with only a few weeks left of the winter blues, our heads — and closets — are ready for the switch. But preparing for transitional spring weather is tricky. Especially after a year like this one, trying to juggle between two wardrobes at once can feel like a lot. That’s where Instagram’s best-dressed come in. From patterned pants and pastel sweaters to oversized trench coats and slouchy suits, there’s a transitional outfit for every style of dresser ahead. All hail the denim tuxedo! It's the peach-tinted sunnies — swipe to see them — for me.Bring on (patchwork) mini dress season.Wear white before Memorial Day, I dare you. Spring colours just make you happier, as proven by this suit.We're green with envy over these fisherman sandal-socks combo. Fact: Crinkly ballet trousers are the trousers of spring 2021. This coat is a true ray of sunshine.Neon leather is the spring combination to look forward to.Spring doesn't mean swearing off joggers — just pick bolder, brighter sets to reflect the uplifting season. Chillier spring days call for a fuzzy polo and an oversized trench.More multicoloured rugby shirts, please! Too hot for a jumper, but too cold for bare arms? Try a knit bolero — we'd be willing to bet it's jussst right. Florals for spring? Ballet flats, berets, and pastel-coloured sweater vests — spring has sprung! McDonald's french fries, but make it fashion.It's clog season, y'all. According to Mona Tougaard, Crocs and DIY tops are this spring's model-off-duty staples.The return of spring means picnic chic is once again relevant.Bring your favourite winter sweaters into spring by opting for off-the-shoulder styles and colourful accents. Good afternoon to this sweater vest and this sweater vest only. Like what you see? How about some more R29 goodness, right here?14 Spring Trends Featured In Zara's Spring LineThe Ultimate Hole-In-One OutfitThese 6 Spring Color Trends Will Brighten Your Day

  • Chin Swee Road death: Woman gets discharge not amounting to acquittal for murder of daughter

    The mother of a two-year-old girl whose remains were found in a flat at Chin Swee Road in 2019 was granted a discharge not amounting to an acquittal over her murder charge on Tuesday (2 March).

  • British grocery sales soar 15% on lockdown boost

    British grocery sales soared 15.1% year-on-year in the four weeks to Feb. 21, the fastest growth since June 2020, as the latest national lockdown curtailed spending in cafes, restaurants and bars, market researcher Kantar said on Tuesday. England entered a third national lockdown on Jan. 4 to contain a surge in COVID-19 cases that threatened to overwhelm the health system. Last week, Prime Minister Boris Johnson announced a road map out of lockdown in which outdoor-only service in restaurants and bars will not return until April 12 at the earliest.

  • SCAsia 21 Kicks-off Student Team Entries for HPC-AI Advisory Council and National Supercomputing Centre (NSCC) Singapore's 4th Annual APAC HPC-AI Competition

    SCAsia 21 Kicks-off Student Team Entries for HPC-AI Advisory Council and National Supercomputing Centre (NSCC) Singapore’s APAC HPC-AI Competition

  • Have your say: Should new drivers have tougher road restrictions after passing their test?

    The government has been asked to reexamine the introduction of graduated driving licences.

  • Record low interest rates until 2024 could deepen divisions between Australia's haves and have-nots

    Record low interest rates until 2024 could deepen divisions between Australia's haves and have-nots . RBA predicts the higher inflation needed to see a rise in rates would not return for at least another three years

  • Rachel Maddow Rips Donald Trump Over ‘Secret’ COVID-19 Vaccination

    “Why did they keep this information secret from the American public?” asked the MSNBC anchor.

  • Repay Holdings Corp (RPAY) Q4 2020 Earnings Call Transcript

    RPAY earnings call for the period ending December 31, 2020.

  • ‘I don’t have money for food’: millions of unemployed in US left without benefits

    ‘I don’t have money for food’: millions of unemployed in US left without benefits. Delays, backlogs of claims and errors have left workers without any unemployment benefits while out of work due to Covid

  • Biden under pressure from progressives as he prepares to pick first judges

    Biden under pressure from progressives as he prepares to pick first judges. President has chance to mitigate some of Trump’s judicial efforts as vacancies arise

  • Tao Geoghegan Hart: 'Everything is political. We are all in this together'

    Tao Geoghegan Hart: 'Everything is political. We are all in this together'The Giro d’Italia winner on taking a knee, lobbying British Cycling and why he ‘could not agree less’ with Zlatan Ibrahimovic Tao Geoghegan Hart takes a knee on Hackney Marshes. ‘I deplore racism,’ he said. ‘I wanted to make my stance clear and lay out actions I hoped to take’. Photograph: Timothy Spurr

  • US men accused of helping Ghosn escape arrive in Japan

    A US father-son pair accused of helping former Nissan boss Carlos Ghosn in his audacious escape from Japan arrived in Tokyo on Tuesday after losing their battle against extradition, local media said.

  • Flutter full-year earnings rise 23%, eyes bigger U.S. pot

    Full year earnings at Paddy Power, Betfair and Poker Stars owner Flutter Entertainment rose by 23%, as it maintained its leading position in a booming U.S. market that it said could grow to twice the size previously estimated. The world's largest online betting group reported full-year 2020 earnings before interest, tax, depreciation and amortisation (EBITDA) of 1.4 billion pounds ($1.9 billion), ahead of the 1.275 billion to 1.350 billion range it forecast in November. That excluded an EBITDA loss of 170 million pounds in the United States, the next big growth market for sports betting, where it merged with the Stars Group Inc (TSG) last May and increased its holding in its U.S. Fanduel brand in November.

  • daVinci Payments "Future of Payments UK" Reveals Continued Desire for Instant Payment Methods and Growing Prevalence of Loyalty Programs

    With the acceleration of digital payments, daVinci Payments released a new national UK study, identifying how people prefer to receive payments.

  • Prepaid Financial Services Is Now Known As EML Payments

    PFS has been fully integrated into EML.

  • This Is the Only Hairstyling Tool You'll Ever Need

    Take it from me.

  • EXCiPACT Certification for c-LEcta’s High Production Standards

    c-LEcta, a global biotechnology company with technology leadership in enzyme engineering and bioprocess development, can significantly reduce the cost of supplier audits for customers thanks to its recent award of EXCiPACT certification. The certificate confirms compliance with particularly high quality standards in production and distribution. For customers from the pharmaceutical industry in particular, these standards are an important criterion for qualifying suppliers and the closure of contracts. The certification significantly eases cooperation with new and existing customers for c-LEcta. EXCiPACT certification is internationally recognized and confirms that c-LEcta complies with "Good Manufacturing Practice" and "Good Distribution Practice" for pharmaceutical excipients.

  • Milan’s Coolest Fashion Girl on the Easy Outfits to Wear This Season

    Allow influencer Alice Perrella to demonstrate.

  • IBA Notice of Full Year 2020 Results and Conference Call

    FY20 Results Conference Call to take place on Thursday, 25 March 2021 at 3pm CET Louvain-la-Neuve, Belgium, 2 March 2021 - IBA (Ion Beam Applications S.A., EURONEXT), the world’s leading provider of proton therapy solutions for the treatment of cancer, announces today that it will publish its consolidated results for the full year 2020 on Thursday, 25 March 2021 at 7am CET. Conference Call Information In addition to the press release, Olivier Legrain, Chief Executive Officer, and Soumya Chandramouli, Chief Financial Officer, will host a conference call and webcast, conducted in English, to present the full year results, followed by a Q&A session. This conference call will be held on Thursday, 25 March 2021 at 3pm CET / 2pm GMT / 10am EDT / 7am PDT and can be accessed online at: http://arkadinemea-events.adobeconnect.com/iba250321/event/registration.html If you would like to participate in the Q&A, please dial (PIN code 24698548#): Belgium: +32 2 403 58 16UK: +44 20 71 94 37 59NL: +31 207 09 51 19LU: +352 2 730 01 63US: +1 64 67 22 49 16FR: +33 1 72 72 74 03 The presentation will be available on IBA’s investor relations website and on:https://iba-worldwide.com/content/iba-full-year-2020-results-web-conference shortly before the call. To ensure a timely connection, it is recommended that users register at least 10 minutes prior to the scheduled webcast. About IBAIBA (Ion Beam Applications S.A.) is a global medical technology company focused on bringing integrated and innovative solutions for the diagnosis and treatment of cancer. The company is the worldwide technology leader in the field of proton therapy, considered to be the most advanced form of radiation therapy available today. IBA’s proton therapy solutions are flexible and adaptable, allowing customers to choose from universal full-scale proton therapy centers as well as compact, single room solutions. In addition, IBA has a radiation dosimetry business and develops particle accelerators for the medical world and industry. Headquartered in Belgium and employing about 1,500 people worldwide, IBA has the largest number of installed proton therapy systems across the world. IBA is listed on the pan-European stock exchange NYSE EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB). More information can be found at www.iba-worldwide.com For further information, please contact: IBACorporate Communication+32 10 47 58 90communication@iba-group.com For media and investor enquiries: Consilium Strategic CommunicationsAmber Fennell, Angela Gray, Lizzie Seeley+44 (0) 20 3709 5700IBA@consilium-comms.com Attachment 210302-FYR2020_Conf-call-announcement_EN

  • Vaccitech Appoints Two Independent Board Directors

    OXFORD, United Kingdom, March 02, 2021 (GLOBE NEWSWIRE) -- Vaccitech Ltd., a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer, today announced the appointment of two new independent directors to its Board of Directors. Dr. Anne Phillips, FRCPC, and Karen A. Dawes, MBA, joined the Board on 17 February 2021. Their appointments add strong independent perspectives on drug development and commercialization to Vaccitech’s Board. “Anne and Karen are truly exceptional and accomplished additions to the Board,” said Robin Wright, Chairman of the Board. “Vaccitech will be able to draw on their deep knowledge of clinical development and commercialization to improve its prospects for rapid growth and development. In addition, the breadth of their experience in the healthcare sector means that they will each be able to bring considerable wisdom to the Board as a whole. We welcome Anne and Karen to Vaccitech and look very much forward to their contributions.” Dr. Phillips has extensive biopharmaceutical product development experience. She currently serves as Senior Vice President Clinical, Medical & Regulatory Affairs at Novo Nordisk, where she has overseen more than a dozen FDA drug approvals. Prior to this, she served in multiple executive roles in drug development at GlaxoSmithKline including Vice President Medicine Development Leader of a leading prostate cancer therapeutic. Before building a long career in the pharmaceutical industry, Dr. Phillips served as Head of Infectious Diseases programs and Deputy Physician-in-chief at Wellesley Central Hospital/St. Michael’s Hospital in Toronto, Canada. Dr. Phillips is based in the USA. “Vaccitech’s ChAdOx-MVA immunotherapy platform induces robust CD8+ T cell responses, which differentiates it from other immunotherapy platforms,” said Dr. Phillips. “The Company is developing candidates that target significant medical needs in oncology and infectious disease and which have the potential to improve patients’ lives.” Ms. Dawes has led a distinguished career as an executive at several biopharmaceutical companies including Bayer Corp., Wyeth Pharmaceuticals, Genetics Institute and Pfizer, where she held leadership roles in business, marketing and commercialization. More recently, Ms. Dawes has led her own successful consultancy company working with emerging companies on corporate strategy and commercial development. Since 2005, Ms. Dawes has served on the boards of several public and private biopharmaceutical companies, and she continues to serve on the boards of Repligen Corp., Medicines 360, Medicenna Therapeutics and PaxMedica Therapeutics. Ms. Dawes is also based in the USA. “Vaccitech is an exciting company with both therapeutic and prophylactic candidates in clinical development in oncology and infectious disease. The Company’s platform technology provides the opportunity to generate many more candidates in the future,” said Ms. Dawes. “I look forward to working with my new colleagues on the Vaccitech Board and with the management team to advance these programs through clinical development and toward commercialization.” About Vaccitech Ltd. Vaccitech is a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer. The company’s proprietary platform comprises proprietary modified simian adenoviral vectors, known as ChAdOx1 and ChAdOx2, as well as the well-validated Modified Vaccinia Ankara, or MVA, boost vector, both with demonstrable safety profiles and without the ability to replicate in humans. The combination of a ChAdOx prime treatment with subsequent MVA boost has consistently generated significantly higher magnitudes of CD8+ T cells compared with other technologies and approaches. The company has a broad pipeline of both clinical and preclinical stage therapeutic programs in solid tumors and viral infections and prophylactic viral vaccine programs. Vaccitech co-invented a COVID-19 vaccine with the University of Oxford, now approved for use in many territories and exclusively licensed worldwide to AstraZeneca through Oxford University Innovation, or OUI. Vaccitech is entitled to receive a share of the milestones and royalty income received by OUI from AstraZeneca. Media contacts: Katja Stout, Scius Communications (EU)Direct: +44 (0) 7789435990Email: katja@sciuscommunications.com Ryo Imai / Robert Flamm, Ph.D. (U.S.)Burns McClellan, Inc.212-213-0006 ext. 315 / 364Rimai@burnsmc.com / rflamm@burnsmc.com Henry Hodge, VaccitechDirect: +44 (0) 7533 421 442Email: henry.hodge@vaccitech.co.uk